Development and validation of nomogram prognostic model for early-stage T1-2N0M0 small cell lung cancer: A population-based analysis

BACKGROUND: Survival outcomes of early-stage T1-2N0M0 small cell lung cancer (SCLC) patients differ widely, and the existing Veterans Administration Lung Study Group (VALSG) or TNM staging system is inefficient at predicting individual prognoses. In our study, we developed and validated nomograms fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Tao, Zhu, Shuncang, Sun, Liangdong, Yin, Laibo, Dai, Jie, Qian, Jiayi, Chen, Xiangru, Zhang, Peng, Zhu, Jialong, Jiang, Gening
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713004/
https://www.ncbi.nlm.nih.gov/pubmed/36465408
http://dx.doi.org/10.3389/fonc.2022.921365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713004/
https://www.ncbi.nlm.nih.gov/pubmed/36465408
http://dx.doi.org/10.3389/fonc.2022.921365

Ejemplares similares